Your browser doesn't support javascript.
COVID-19 Public Stigma Scale (COVID-PSS): development, validation, psychometric analysis and interpretation.
Nochaiwong, Surapon; Ruengorn, Chidchanok; Awiphan, Ratanaporn; Kanjanarat, Penkarn; Ruanta, Yongyuth; Phosuya, Chabaphai; Boonchieng, Waraporn; Nanta, Sirisak; Chongruksut, Wilaiwan; Thavorn, Kednapa; Wongpakaran, Nahathai; Wongpakaran, Tinakon.
  • Nochaiwong S; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand surapon.nochaiwong@gmail.com.
  • Ruengorn C; Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Awiphan R; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Kanjanarat P; Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Ruanta Y; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Phosuya C; Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Boonchieng W; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Nanta S; Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Chongruksut W; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Thavorn K; Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Wongpakaran N; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Wongpakaran T; Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
BMJ Open ; 11(11): e048241, 2021 11 02.
Article in English | MEDLINE | ID: covidwho-1501712
ABSTRACT

OBJECTIVE:

Amid the COVID-19 pandemic, social stigma towards COVID-19 infection has become a major component of public discourse and social phenomena. As such, we aimed to develop and validate the COVID-19 Public Stigma Scale (COVID-PSS). DESIGN AND

SETTING:

National-based survey cross-sectional study during the lockdown in Thailand.

PARTICIPANTS:

We invited the 4004 adult public to complete a set of measurement tools, including the COVID-PSS, global fear of COVID-19, perceived risk of COVID-19 infection, Bogardus Social Distance Scale, Pain Intensity Scale and Insomnia Severity Index.

METHODS:

Factor structure dimensionality was constructed and reaffirmed with model fit by exploratory and confirmatory factor analyses and non-parametric item response theory (IRT) analysis. Psychometric properties for validity and reliability were tested. An anchor-based approach was performed for classifying the proper cut-off scores.

RESULTS:

After factor analysis, IRT analysis and test for model fit, we created the final 10-item COVID-PSS with a three-factor structure stereotype, prejudice and fear. Face and content validity were established through the public and experts' perspectives. The COVID-PSS was significantly correlated (Spearman rank, 95% CI) with the global fear of COVID-19 (0.68, 95% CI 0.66 to 0.70), perceived risk of COVID-19 infection (0.79, 95% CI 0.77 to 0.80) and the Bogardus Social Distance Scale (0.50, 95% CI 0.48 to 0.53), indicating good convergent validity. The correlation statistics between the COVID-PSS and the Pain Intensity Scale and Insomnia Severity Index were <0.2, supporting the discriminant validity. The reliability of the COVID-PSS was satisfactory, with good internal consistency (Cronbach's α of 0.85, 95% CI 0.84 to 0.86) and test-retest reproducibility (intraclass correlation of 0.94, 95% CI 0.86 to 0.96). The proposed cut-off scores were as follows no/minimal (≤18), moderate (19-25) and high (≥26) public stigma towards COVID-19 infection.

CONCLUSIONS:

The COVID-PSS is practical and suitable for measuring stigma towards COVID-19 in a public health survey. However, cross-cultural adaptation may be needed.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Social Stigma / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2020-048241

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Social Stigma / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2020-048241